Follow Building in Public Podcast: https://x.com/builtnpublicpod

In this episode, Aldo de Pape, the founder of GenomesDAO, discussed the challenges facing the genetic testing industry and how his organization is addressing them. He highlighted concerns around privacy and security, particularly in light of the increasing number of healthcare data breaches. GenomesDAO's approach prioritizes the safety and ownership of genomic data, contrasting their model with companies like 23andMe by ensuring individuals retain control over their biological samples and data via blockchain technology and partnerships with companies like AMD. Aldo also explained how GenomesDAO’s consent protocol allows individuals to be compensated for sharing their data with research partners, such as pharmaceutical companies. He discussed the value of genomic data and the ways users can engage with the platform, either by ordering a genetic testing kit or transferring data from other platforms. The episode also covered the demand side of GenomesDAO's business model, where the platform serves as secure infrastructure for genomic research, with growing interest from pharmaceutical companies. Through its focus on data ownership, security, and user empowerment, GenomesDAO is reshaping the genetic testing landscape.

Timestamps:

00:00 - Introduction

00:32 - Genomic Data and Privacy Concerns

02:20 - Challenges in the Genetic Testing Industry

03:58 - GenomesDAO's Mission and Approach

04:18 - Security Measures Compared to Traditional Companies

07:39 - Monetization and Data Ownership Issues

08:27 - Consent and User Engagement

10:42 - Getting Involved with GenomesDAO

12:21 - Point System and Health Reports

18:13 - Token Launch and Blockchain Details

19:13 - Building on BASE and Ecosystem Synergies

20:58 - Demand Side and Research Partnerships

25:08 - Conclusion

Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.